From: https://www.diseasewiki.com
What are the effects of thymic peptide enteric-coated capsules?
Thymic peptide enteric-coated capsules have a wide range of uses, with the most prominent effect being the ability to enhance human immunity. If the human immune system is compromised, many immune diseases may occur, such as systemic lupus erythematosus, a well-known immune disease. Once this disease occurs, patients may experience generalized weakness, become weak, and their weight may gradually decrease. With the progression of the disease, joint pain may occur, which can further lead to arthritis. In severe cases, joint deformities may occur. Therefore, it is important to avoid the progression of the disease. Patients can receive treatment with thymic peptide enteric-coated capsules as early as possible. In addition, this capsule has many other benefits.
First, efficacy and action:
1. It is used for patients with chronic hepatitis B aged 18 years and older. Since the thymus begins to atrophy after the age of 18, cellular immune function decreases;
2. Various primary or secondary T-cell deficiency diseases;
3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.);
4. Various diseases with low cellular immune function; 5. Adjunctive therapy for tumors.
Second, adverse reactions:
1. It has good tolerance, with some patients experiencing adverse reactions such as nausea, fever, dizziness, chest tightness, and fatigue. A few patients may occasionally feel drowsy.
2. In patients with chronic hepatitis B, the ALT level may transiently rise during treatment, but the use of this product can continue if there are no signs of liver failure.
Third, precautions:
1. This product exerts a therapeutic effect by enhancing the immune function of patients, therefore, it should not be used in patients receiving immunosuppressive therapy (such as organ transplant recipients) unless the benefits of treatment clearly outweigh the risks.
2. Liver function should be regularly checked during treatment.
3. Caution should be exercised in the use of this product for patients under 18 years of age.
Fourth, medication for pregnant and lactating women
Animal fertility studies have shown that there is no difference in the impact on embryos between the control group and the treatment group with this drug. It is currently unknown whether this drug is harmful to the embryo or affects fertility. Therefore, this drug should only be administered to pregnant women when absolutely necessary. Although this product has not been confirmed to be excreted through human milk, it should still be used with caution in lactating women.
Fifth, drug interactions
(1) This product can be used in combination with many commonly used drugs, including interferon, anti-inflammatory drugs, antibiotics, hormones, analgesics, antihypertensive drugs, diuretics, drugs for treating cardiovascular diseases, central nervous system drugs, and contraceptives, without any interference phenomena.
(2) When used in combination with interferon, this product has a synergistic effect on improving immune function.
